Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices 3985 

Controlled substance Schedule 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Ecgonine (9180) ........................... II 

Hydrocodone (9193) ..................... II 

Levorphanol (9220) ...................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Opium tincture (9630) .................. II 

Opium, powdered (9639) ............. II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Alfentanil (9737) ........................... II 

Remifentanil (9739) ...................... II 

Sufentanil (9740) .......................... II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances for 

internal use and for distribution to other 

companies. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01304 Filed 1–23–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Chattem 

Chemicals, Inc. 

ACTION: Notice of registration. 

SUMMARY: Chattem Chemicals, Inc. 

applied to be registered as a 

manufacturer of certain basic classes of 

controlled substances. The DEA grants 

Chattem Chemicals, Inc. registration as 

a manufacturer of those controlled 

substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated August 27, 2014, and published in 

the Federal Register on September 4, 

2014, 79 FR 52764, Chattem Chemicals, 

Inc., 3801 St. Elmo Avenue, 

Chattanooga, Tennessee 37409, applied 

to be registered as a manufacturer of 

certain basic classes of controlled 

substances. No comments or objections 

were submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Chattem Chemicals, Inc. to manufacture 

the basic classes of controlled 

substances is consistent with the public 

interest and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

May 1, 1971. The DEA investigated the 

company’s maintenance of effective 

controls against diversion by inspecting 

and testing the company’s physical 

security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed: 

Controlled substance Schedule 

Gamma Hydroxybutyric Acid 

(2010).

I 

4-Methoxyamphetamine (7411) ... I 

Dihydromorphine (9145) ............... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Lisdexamfetamine (1205) ............. II 

Methylphenidate (1724) ................ II 

Pentobarbital (2270) ..................... II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Hydrocodone (9193) ..................... II 

Meperidine (9230) ........................ II 

Meperidine intermediate-A (9232) II 

Meperidine intermediate-B (9233) II 

Meperidine intermediate-C (9234) II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Morphine (9300) ........................... II 

Oripavine (9330) ........................... II 

Thebaine (9333) ........................... II 

Opium tincture (9630) .................. II 

Opium, powdered (9639) ............. II 

Opium, granulated (9640) ............ II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Alfentanil (9737) ........................... II 

Remifentanil (9739) ...................... II 

Sufentanil (9740) .......................... II 

Tapentadol (9780) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution and sale to its 

customers. Regarding (9640) the 

company plans to manufacture another 

controlled substance for sale to its 

customers. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01308 Filed 1–23–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Wildlife 

Laboratories, Inc. 

ACTION: Notice of registration. 

SUMMARY: Wildlife Laboratories, Inc. 

applied to be registered as a 

manufacturer of a basic class of 

controlled substance. The DEA grants 

Wildlife Laboratories, Inc. registration 

as a manufacturer of this controlled 

substance. 

SUPPLEMENTARY INFORMATION: By notice 

dated May 28, 2014, and published in 

the Federal Register on June 3, 2014, 79 

FR 31985, Wildlife Laboratories, Inc., 

1230 W. Ash Street, Suite D, Windsor, 

Colorado 80550, applied to be registered 

as a manufacturer of a certain basic class 

of controlled substance. No comments 

or objections were submitted to this 

notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Wildlife Laboratories, Inc. to 

manufacture the basic class of 

controlled substance is consistent with 

the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971. The DEA 

investigated the company’s maintenance 

of effective controls against diversion by 

inspecting and testing the company’s 

physical security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of Carfentanil (9743), a 

basic class of controlled substance listed 

in schedule II. 

The company plans to manufacture 

the above listed controlled substance for 

sale to veterinary pharmacies, zoos, and 

other animal and wildlife applications. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01294 Filed 1–23–15; 8:45 am] 

BILLING CODE P 


emcdonald on DSK67QTVN1PROD with NOTICES